In an extended cohort of 70 CSLs (tumor, matched normals, and controls), a recurrent C > T single-nucleotide variant in exon 4 of <i>CD274/PD-L1</i> was identified in 54 of 68 (79.4%) CSLs with diagnosed UGC. Here, CD274 is linked to neoplasm.